Sex as a major determinant of pro-longevity drug efficacy: a review of two decades of the NIA Interventions Testing Program
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 2025
DOI: 10.1093/gerona/glaf138 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2025. Verfasst von Nisi Jiang und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Sam and Ann Barshop Institute for Longevity and Aging Studies, UT Health San Antonio, San Antonio, Texas, United States. Hauptthemen laut MEDLINE: Longevity, Aging. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIA NIH HHS, Center for Testing Potential Anti-Aging Interventions.
Abstract (Originalsprache)
Aging is the primary risk factor for frailty, sarcopenia, and functional decline, as well as cancer, cardiovascular and neurodegenerative diseases. Gaining insight into the biological mechanisms of aging could lead to interventions that broadly reduce age-related morbidity and mortality. To identify interventions that extend lifespan and delay aging, the National Institute on Aging launched the Interventions Testing Program (ITP) in 2004. This multi-site effort uses genetically heterogeneous UM-HET3 mice to evaluate the effects of candidate compounds. Over the past two decades, the ITP has tested 54 agents in more than 30, 000 mice. This is the first comprehensive review of the program’s results, with particular emphasis on a striking pattern of sex-specific responses. By presenting the full scope of the findings, readers can better understand the overall impact of the program and easily access detailed information on specific drugs of interest. Notably, most compounds that extended lifespan were effective primarily or exclusively in male mice. Dosage and age of treatment onset influenced efficacy and were also sexually dimorphic. These sex differences suggest that mechanisms of aging are sexually dimorphic and highlight the importance of recognizing biological sex as a modifier of treatment efficacy. Investigating the basis for these differences should enable more targeted and effective geroprotective strategies for both sexes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Sam and Ann Barshop Institute for Longevity and Aging Studies, UT Health San Antonio, San Antonio, Texas, United States.
- Department of Cellular and Integrative Physiology, UT Health San Antonio, San Antonio, Texas, United States.
- Department of Medicine, UT Health San Antonio, San Antonio, Texas, United States.
- Department of Population Health Sciences, UT Health San Antonio, San Antonio, Texas, United States.
- Department of Pharmacology, UT Health San Antonio, San Antonio, Texas, United States.
- South Texas Veterans Health Care System, San Antonio, Texas, United States.
ORCID-Profile: Nisi Jiang, Ziying Xu, Shangang Zhao, Jonathan Gelfond, Randy Strong, James F Nelson
Förderung
- NIH HHS
- NIA NIH HHS
- Center for Testing Potential Anti-Aging Interventions
- NIDDK NIH HHS
- Nathan Shock Center of Excellence in Basic Biology of Aging
- VA
- NIH
- Department of Veterans Affairs
Zitieren
APA
Jiang, N., Xu, Z., Zhao, S., Gelfond, J., Strong, R., & Nelson, J. F. (2025). Sex as a major determinant of pro-longevity drug efficacy: a review of two decades of the NIA Interventions Testing Program. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. https://doi.org/10.1093/gerona/glaf138
Vancouver
Jiang N, Xu Z, Zhao S, Gelfond J, Strong R, Nelson JF. Sex as a major determinant of pro-longevity drug efficacy: a review of two decades of the NIA Interventions Testing Program. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2025. doi:10.1093/gerona/glaf138
BibTeX
@article{Jiang2025,
author = {Jiang, Nisi and Xu, Ziying and Zhao, Shangang and Gelfond, Jonathan and Strong, Randy and Nelson, James F},
title = {Sex as a major determinant of pro-longevity drug efficacy: a review of two decades of the NIA Interventions Testing Program},
journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
year = {2025},
doi = {10.1093/gerona/glaf138}
}
EUVIMED